Moderna, Inc. has announced promising early results from its investigational cancer therapy, mRNA-4359. This data will be presented at the 2025 European Society for Medical Oncology...
Research presented by Hossein Borghaei, DO, MS, at the 26th Annual International Lung Cancer Congress suggests that innovative treatment approaches could enhance outcomes for patients with...
